LOADINGERROR LOADING
President Donald Trump had to be begged not to spill the beans about a seismic change to U.S. drug policy made this month, according to a report from The Wall Street Journal published on Saturday.
After extensive lobbying and some generous donations from major players in the marijuana industry, the president was convinced to follow through with his campaign promise to shift cannabis from a Schedule I to Schedule III substance during a meeting with Kim Rivers, the CEO of Florida-based cannabis company Trulieve, Trump confidante Howard Kessler and Florida Sheriff Gordon Smith in early December.
Advertisement
Eager to share the news immediately, Trump told the people in the room he planned to announce the decision on Truth Social before an executive order was even drafted.
Smith remembered things getting heated as Oval Office insiders tried to stop their boss from blabbing, according to the Journal.
President Donald Trump pictured after signing an executive order reclassifying marijuana as a schedule III drug on December 18, 2025.Anna Moneymaker via Getty ImagesAdvertisement
“The lawyers and his staff, they started yelling, ’No sir, you can’t yet; there’s a 30-day period, it’s gotta go through this and that,” Smith recalled.“They had to stop him from